News & Events

Announcement of Acquisition of Shares (Ownership) in Icon Genetics GmbH by DENKI KAGAKU KOGYO KABUSHIKI KAISHA,Aug`15

Icon Genetics successfully completes Phase I clinical study with personalized vaccines for treatment of non-Hodgkin's lymphoma,Jan`14

Icon Genetics and Bayer CropScience successfully completed the development of a plant host system with designer glycosylation needed for manufacturing biopharmaceuticals in green plants,Dec`13

Icon Genetics’ personalized vaccine clinical trials is featured in documentary series from Baylor Health Care System,Nov`12

Icon Genetics to Provide John Innes Centre Access to Golden Gate Cloning Platform,Sep`12

CSIR gets free access to Icon Genetics manufacturing technology,Jul`12

Frost & Sullivan's to recognize Icon Genetics with the 2012 European Technology Innovation Award.,Jun`12

Icon Genetics and Bayer CropScience sign an agreement to develop production hosts with designer glycosylation,May`12

Kentucky Bioprocessing, Icon Genetics and Mapp Biopharmaceutical have entered into discussions to merge their businesses,May`12

Nomad Bioscience and Icon Genetics sign broad cross-license agreement ,Mar`12

Nomad Bioscience enters into comprehensive agreement with Bayer Innovation,Jan`12

Bayer starts clinical Phase I study with personalized vaccine from tobacco plants,Jan`10

Pilot plant for future-oriented technology opens in Halle,Jun`08

Icon Genetics and Bayer CropScience publish milestone paper about the production of antibodies in plants,Sep`06

Bayer acquires Icon Genetics AG,Jan`06

KTRDC and Icon Genetics Announce Joint Field Trial Experiment in the United States,Jul`05

Icon Genetics to Publish Milestone Research Paper Describing its Magnifection Expression Technology,May`05

Icon Genetics AG and University of Munich awarded funding from Bavarian Research Foundation for the development of transgene switches,Apr`05

Large Scale Biology Corporation and Icon Genetics Announce Product Development Collaboration,Mar`05

Icon Genetics Announces Strategic Research Alliance with Bayer CropScience,Jan`05

Icon Genetics AG and Holtz BioPharma Consulting Complete Phase I Collaboration,Jan`05

Protalix Biotherapeutics and Icon Genetics Awarded BIO-DISC funding for Israeli-German Biotechnology Cooperation,Nov`04

Drug Production in Transgenic Plants - Icon Genetics and Berlex Join Strategic Alliance,Aug`04

New Hybrid Seed System for Winter Wheat - Nordsaat Saatzucht and Icon Genetics to Collaborate on the Development of a New Genetic Hybrid Seed System for Winter Wheat,Jul`04

Protalix Biotherapeutics and Icon Genetics to Collaborate on High-level Expression of Recombinant Proteins in Plant Cell Cultures,Jun`04

Icon Genetics to Publish Milestone Research Paper Describing its magnICON Expression Technology,Apr`04

Transgenic Plants Free of Antibiotic Selection Marker,Feb`04

Icon Genetics and Novoplant announce broad license agreement,Oct`03

Icon Genetics Completes its Second Round of Financing,Apr`03

Icon Genetics Secures Venture Capital and Licenses its Transgene Operating Systems™ to Xios Biosciences, Inc.,Mar`02

Degussa BioActives and Icon Genetics sign a two-year Research Cooperation Agreement,Feb`02

Large Scale Biology and Icon Genetics Announce Identification of Gene Sequences for Use in Commercial Plant Varieties,Apr`01

Ministry of Bavaria Announces Financial Support for Icon Genetics at Inauguration of Freising-Weihenstephan Research Centre,Oct`00

Icon Genetics Secures Funds and Opens Laboratories in Germany ,Jan`00

Icon Genetics Inc. Announces Establishment of Icon Genetics AG in Munich, Germany,Oct`99

New Agricultural Biotechnology Company founded to focus on faster and safer methods for making genetically engineered crops,Jun`99

News & Events

Icon Genetics’ personalized vaccine clinical trials is featured in documentary series from Baylor Health Care System,November`12

Icon Genetics to Provide John Innes Centre Access to Golden Gate Cloning Platform,September`12

CSIR gets free access to Icon Genetics manufacturing technology,July`12

Frost & Sullivan's to recognize Icon Genetics with the 2012 European Technology Innovation Award.,June`12

Icon Genetics and Bayer CropScience sign an agreement to develop production hosts with designer glycosylation,May`12

Kentucky Bioprocessing, Icon Genetics and Mapp Biopharmaceutical have entered into discussions to merge their businesses,May`12

Nomad Bioscience and Icon Genetics sign broad cross-license agreement ,Mar`12

Nomad Bioscience enters into comprehensive agreement with Bayer Innovation,Jan`12

Bayer starts clinical Phase I study with personalized vaccine from tobacco plants,Jan`10

Pilot plant for future-oriented technology opens in Halle,Jun`08

Icon Genetics and Bayer CropScience publish milestone paper about the production of antibodies in plants,Sep`06

Bayer acquires Icon Genetics AG,Jan`06

KTRDC and Icon Genetics Announce Joint Field Trial Experiment in the United States,Jul`05

Icon Genetics to Publish Milestone Research Paper Describing its Magnifection Expression Technology,May`05

Icon Genetics AG and University of Munich awarded funding from Bavarian Research Foundation for the development of transgene switches,Apr`05

Large Scale Biology Corporation and Icon Genetics Announce Product Development Collaboration,Mar`05

Icon Genetics Announces Strategic Research Alliance with Bayer CropScience,Jan`05

Icon Genetics AG and Holtz BioPharma Consulting Complete Phase I Collaboration,Jan`05

Protalix Biotherapeutics and Icon Genetics Awarded BIO-DISC funding for Israeli-German Biotechnology Cooperation,Nov`04

Drug Production in Transgenic Plants - Icon Genetics and Berlex Join Strategic Alliance,Aug`04

New Hybrid Seed System for Winter Wheat - Nordsaat Saatzucht and Icon Genetics to Collaborate on the Development of a New Genetic Hybrid Seed System for Winter Wheat,Jul`04

Protalix Biotherapeutics and Icon Genetics to Collaborate on High-level Expression of Recombinant Proteins in Plant Cell Cultures,Jun`04

Icon Genetics to Publish Milestone Research Paper Describing its magnICON Expression Technology,Apr`04

Transgenic Plants Free of Antibiotic Selection Marker,Feb`04

Icon Genetics and Novoplant announce broad license agreement,Oct`03

Icon Genetics Completes its Second Round of Financing,Apr`03

Icon Genetics Secures Venture Capital and Licenses its Transgene Operating Systems™ to Xios Biosciences, Inc.,Mar`02

Degussa BioActives and Icon Genetics sign a two-year Research Cooperation Agreement,Feb`02

Large Scale Biology and Icon Genetics Announce Identification of Gene Sequences for Use in Commercial Plant Varieties,Apr`01

Ministry of Bavaria Announces Financial Support for Icon Genetics at Inauguration of Freising-Weihenstephan Research Centre,Oct`00

Icon Genetics Secures Funds and Opens Laboratories in Germany ,Jan`00

Icon Genetics Inc. Announces Establishment of Icon Genetics AG in Munich, Germany,Oct`99

New Agricultural Biotechnology Company founded to focus on faster and safer methods for making genetically engineered crops,Jun`99